Smoking cessation and lung cancer: oncology nurses can make a difference.

Cantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Seminars in Oncology Nursing 03/2008; 24(1):16-26. DOI: 10.1016/j.soncn.2007.11.008
Source: PubMed

ABSTRACT To provide an overview of the impact of smoking after a diagnosis of lung cancer, discuss the relationship between smoking cessation and improved outcomes, present information about tobacco-dependence treatments, reimbursement for these treatments, and resources available for patients and health care professionals.
Published articles, reports, websites, and research studies.
Prevention of tobacco use and cessation are primary ways to prevent lung cancer. However, even after a diagnosis of lung cancer, smoking cessation is important in improving survival and quality of life. Although effective treatments are available to help smokers quit, persistent efforts over repeated contacts may be necessary to achieve long-term cessation.
Oncology nursing action is essential in the identification of and intervention with patients who struggle with tobacco dependence after diagnosis.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The evolution of supportive care in lung cancer (LC) is the focus of the current paper, which aims to present an overall picture of the developments in the field, highlight milestones over the past four decades and provide directions for future research and practice. While in the 1970s this work was minimal, from the 1980s onwards, there was an expansion of the range of topics covered in the literature, reflecting the importance of supportive care to clinical practice. These areas include the identification of supportive care needs in LC, symptoms and symptom management, psychosocial aspects and coping with LC (including support of caregivers), quality of life issues and the development and testing of patient-reported outcomes, the option of best supportive care vs. treatment, smoking cessation prior to and after diagnosis of LC, and service delivery models.This paper celebrates the evolution of supportive LC care over the past 40 years alongside recognising that more work needs to be done in the future and new research foci need to be developed to meet the current needs of patients with LC. The role and the continuous efforts of the International Association of the Study of Lung Cancer (IASLC), including the 16 World Conference on Lung Cancer in 2015 to meet this goal, will be crucial and strategic in the future.
    Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 10/2014; 10(1). DOI:10.1097/JTO.0000000000000407 · 5.80 Impact Factor
  • Source
    Canadian respiratory journal: journal of the Canadian Thoracic Society 02/2015; · 1.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Le tabagisme est un problème majeur de santé publique. Le tabac, première cause évitable de mortalité, tue chaque année 5 millions de personnes dans le monde et 73 000 en France. Il est responsable de 9 cancers bronchiques sur 10. Le tabagisme augmente le risque de complications post-opératoires et diminue la tolérance et l’efficacité des traitements médicaux (chimiothérapie, thérapie ciblée, radiothérapie). La poursuite du tabagisme a un effet délétère sur la survie des patients. De plus, les malades fumeurs ont une moins bonne qualité de vie et un risque accru de second cancer. L’arrêt du tabac est un élément essentiel de la prise en charge thérapeutique d’un patient atteint de cancer bronchique. L’efficacité des programmes d’aide à l’arrêt du tabac chez les fumeurs atteints de cancer bronchique est démontrée. Le sevrage tabagique doit comporter : éducation thérapeutique, traitements médicamenteux (substituts nicotiniques, varénicline ou bupropion) et soutien psychologique. Les approches pluridisciplinaires augmentent le taux de succès du sevrage tabagique.
    Revue des Maladies Respiratoires Actualites 09/2014; 6(4). DOI:10.1016/S1877-1203(14)70585-3